share_log

Gilead Sciences | 8-K: Gilead Sciences Announces Completion of Acquisition of CymaBay Therapeutics and Enters into an Agreement and Plan of Merger with Wholly-Owned Subsidiary Pacific Merger Sub

Gilead Sciences | 8-K: Current report

吉利德科学 | 8-K:重大事件
美股SEC公告 ·  2024/03/22 21:22
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息